Medium term results of HEMA intraocular lenses (Hydroview®)

A group of 232 eyes that received a HEMA IOL (Hydroview, Storz Inc.) was followed over a period of six months. Mean visual acuity increased from 0.41 preoperatively to 0.79 post-operatively. During the follow-up period, the visual acuity remained stable in 175 eyes and decreased in 57 eyes, mainly d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bulletin de la Société Belge d'Ophtalmologie 1999, Vol.272, p.63-68
Hauptverfasser:	GOARNISSON, S, HENNEKES, R
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Biological and medical sciences Cataract Extraction Female Follow-Up Studies Humans Hydrogel, Polyethylene Glycol Dimethacrylate Lenses, Intraocular Male Medical sciences Middle Aged Ophthalmologic Surgical Procedures Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the eye and orbit Treatment Outcome Visual Acuity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A group of 232 eyes that received a HEMA IOL (Hydroview, Storz Inc.) was followed over a period of six months. Mean visual acuity increased from 0.41 preoperatively to 0.79 post-operatively. During the follow-up period, the visual acuity remained stable in 175 eyes and decreased in 57 eyes, mainly due to progression of ARMD and posterior capsule opacification (PCO). Nine eyes required YAG-laser capsulotomy. Cell migration on the anterior surface of the Hydroview IOL was observed in 100% of the cases after a period of 3 months.
ISSN:	0081-0746